About Miracalus Pharma Private Limited
Data last updated:
Miracalus Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2007PTC171043. Its GSTIN is 27AAFCM0866N1Z0 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.73 Lakh. It is led by directors including Manish Babulal Jain and Mohan Babulal Jain.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 Town Centre Near Mittal Estate Andheri – Kurla Road Andheri (E), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.12 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹51.8 Lakh (net margin 4.3%) and EBITDA of ₹61.73 Lakh (EBITDA margin 5.1%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 11% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Miracalus Pharma. As per MCA filings, the company has satisfied charges of ₹10 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website miracalus.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address304 Town Centre Near Mittal Estate Andheri – Kurla Road Andheri (E), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Miracalus Pharma Private Limited
The main business activity of Miracalus Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Miracalus Pharma Private Limited FY 2025 filings available
Miracalus Pharma Private Limited reported revenue of ₹12.12 Cr (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Miracalus Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 18% fall in the latest year. EBITDA rose 217% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Miracalus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹61.73 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹51.8 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Miracalus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Miracalus Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Miracalus Pharma Private Limited
Miracalus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maximaa Systems Limited Listed | ₹12.2 Cr (FY 2019) | •••• | •••• | -2.0% | •••• | Valsad, Gujarat, India |
| Francis Remedies (India) Private Limited | ₹12.19 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Delhi, India |
| Medglobe Therapeutics Limited | ₹12.16 Cr (FY 2022) | •••• | •••• | 118.0% | •••• | Delhi, India |
| Mac Organics Pvt.Ltd. | ₹12.15 Cr (FY 2023) | •••• | •••• | 2.0% | •••• | Panvel, Maharashtra, India |
| Tanishka Pharmaceuticals Private Limited | ₹12.13 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Solan, Himachal Pradesh, India |
| Miracalus Pharma Private Limited this company | ₹12.12 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Religrace Parentral India Private Limited | ₹12.11 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Dewas, Madhya Pradesh, India |
| Kayvee Aero Pharm Pvt Ltd | ₹12.1 Cr (FY 2025) | •••• | •••• | 77.0% | •••• | Kadi, Gujarat, India |
| Devyam Medicare Private Limited | ₹12.08 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Kolkata, West Bengal, India |
| Abhimantrit Guruprasadam Ayurveda Herbal Foods Private Limited | ₹12.06 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| Cureton Biotech Private Limited | ₹12.06 Cr (FY 2025) | •••• | •••• | 157.0% | •••• | Haridwar, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Miracalus Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Miracalus Pharma Private Limited
Miracalus Pharma Private Limited is audited by Sohan S. Jain and Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sohan S. Jain and Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Miracalus Pharma Private Limited
Miracalus Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Babulal Jain Also directs: Medorbis Trade LLP, Naprod Life Sciences Private Limited, Samrudh Pharmaceuticals Private Limited and 2 more | Director | 11 Sep 2018 | 8 Years 0 Months | Current |
| Mohan Babulal Jain Also directs: Medorbis Trade LLP, Naprod Life Sciences Private Limited, Samrudh Pharmaceuticals Private Limited and 2 more | Director | 22 May 2007 | 19 Years 4 Months | Current |
| Aarya Mohan Jain Also directs: Medorbis Trade LLP, Naprod Life Sciences Private Limited, Mac-Chem Products (India) Private Limited and 1 more | Director | 13 Mar 2025 | 1 Years 6 Months | Current |
Ownership and Shareholding of Miracalus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Miracalus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2015 | Bank of Baroda | ₹5.5 Cr | Satisfied |
| 25 Jul 2011 | Icici Bank Limited | ₹4.5 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Miracalus Pharma Private Limited
Miracalus Pharma Private Limited has 3 court cases on record: 2 filed by Miracalus Pharma, 1 filed against it. 2 cases are pending and 1 is disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Shree Sambhav Pharma | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Miracalus Pharma Private Limited
Miracalus Pharma operates one associated brand: Miracalus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of branded generics for cancer | miracalus.com |
Employees and EPFO Compliance at Miracalus Pharma Private Limited
Miracalus Pharma Private Limited has a workforce of 21 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Miracalus Pharma Private Limited
Miracalus Pharma Private Limited has 9 board changes on record since 2007: 3 appointments and 6 cessations. The latest: Aarya Mohan Jain ceased to be Additional Director on 25 Sep 2025.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Miracalus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Miracalus Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Miracalus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Miracalus Pharma Private Limited
Miracalus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCM0866N1Z0 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Miracalus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miracalus Pharma Private Limited
Miracalus Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 May 2007 (19+ years old) and is registered under CIN U24230MH2007PTC171043.
Miracalus Pharma reported revenue of ₹12.12 Cr for FY 2025 (down 18% YoY).
Miracalus Pharma has 3 current directors:
- Manish Babulal Jain - Director
- Mohan Babulal Jain - Director
- Aarya Mohan Jain - Director
Miracalus Pharma reported a net profit of ₹51.8 Lakh (net margin 4.3%) and EBITDA of ₹61.73 Lakh (EBITDA margin 5.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Miracalus Pharma is -19% over three years and -11% over five years. In the latest year (FY 2025) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Miracalus Pharma is 27AAFCM0866N1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Miracalus Pharma is U24230MH2007PTC171043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Miracalus Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.
Miracalus Pharma was incorporated on 22 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Miracalus Pharma by revenue are Maximaa Systems Limited, Francis Remedies (India) Private Limited, Medglobe Therapeutics Limited, Mac Organics Pvt.Ltd, Tanishka Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Aarya Mohan Jain ceased to be Additional Director on 25 Sep 2025. Aarya Mohan Jain was appointed as Director on 13 Mar 2025. Kamala Babulal Jain ceased to be Director on 18 Aug 2023. Miracalus Pharma has 9 board changes on record in total.